These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Mirapex (pramipexole) in the treatment of non-motor disturbances in Parkinson's disease]. Nodel' MR; Iakhno NN Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(5):32-8. PubMed ID: 18577955 [TBL] [Abstract][Full Text] [Related]
3. Non-motor symptoms in Parkinson's disease. Park A; Stacy M J Neurol; 2009 Aug; 256 Suppl 3():293-8. PubMed ID: 19711119 [TBL] [Abstract][Full Text] [Related]
4. [Psychiatric complications of Parkinson's disease: their symptoms and treatment]. Castro-García A; Sesar-Ignacio A; Ares-Pensado B Rev Neurol; 2004 Oct 1-15; 39(7):646-50. PubMed ID: 15490352 [TBL] [Abstract][Full Text] [Related]
5. Depression in Parkinson's disease. Ossowska K; Lorenc-Koci E Pharmacol Rep; 2013; 65(6):1545-57. PubMed ID: 24553003 [TBL] [Abstract][Full Text] [Related]
6. Medical treatment of Parkinson disease. Stacy M Neurol Clin; 2009 Aug; 27(3):605-31, v. PubMed ID: 19555824 [TBL] [Abstract][Full Text] [Related]
7. Treatment of Parkinson's disease. Psychological disorders: striking a balance in order to optimise antiparkinsonian treatment. Prescrire Int; 2011 Oct; 20(120):242-5. PubMed ID: 21970092 [TBL] [Abstract][Full Text] [Related]
8. [Pathophysiology, clinical aspects and therapy of sleep disorders in Parkinson disease]. Högl B; Wetter TC; Trenkwalder C Nervenarzt; 2001 Jun; 72(6):416-24. PubMed ID: 11433700 [TBL] [Abstract][Full Text] [Related]
9. Sleep patterns in depression and anxiety: theory and pharmacological effects. Sandor P; Shapiro CM J Psychosom Res; 1994; 38 Suppl 1():125-39. PubMed ID: 7799244 [TBL] [Abstract][Full Text] [Related]
10. Piecing together the puzzle of progression and mortality in Parkinson's disease. Marras C; Oakes D Br J Clin Pharmacol; 2012 Aug; 74(2):264-6. PubMed ID: 22554391 [No Abstract] [Full Text] [Related]
12. [Emotional and cognitive disorders in Parkinson disease]. Arsland D; Larsen JP Tidsskr Nor Laegeforen; 1998 Oct; 118(25):3959-63. PubMed ID: 9830342 [TBL] [Abstract][Full Text] [Related]
13. [Sleep disturbances and depression: a challenge for antidepressants]. Lem RV Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):75-8. PubMed ID: 19256091 [No Abstract] [Full Text] [Related]
14. Authors' response to Marras and Oakes, 'Piecing together the puzzle of progression and mortality in Parkinson's disease'. Holford NH; Vu TC; Nutt JG Br J Clin Pharmacol; 2013 May; 75(5):1370-1. PubMed ID: 22989096 [No Abstract] [Full Text] [Related]
15. Author reply to Holford, Vu and Nutt regarding 'Piecing together the puzzle of progression and mortality in Parkinson's disease'. Marras C; Oakes D Br J Clin Pharmacol; 2013 May; 75(5):1372. PubMed ID: 22989073 [No Abstract] [Full Text] [Related]
16. Nonmotor Symptoms in Experimental Models of Parkinson's Disease. Titova N; Schapira AHV; Chaudhuri KR; Qamar MA; Katunina E; Jenner P Int Rev Neurobiol; 2017; 133():63-89. PubMed ID: 28802936 [TBL] [Abstract][Full Text] [Related]
17. The use of antidepressant medication in Parkinson's disease patients is not affected by the type of antiparkinson medication. Krøigård T; Christensen J; Wermuth L; Ritz B; Lassen CF J Parkinsons Dis; 2014; 4(3):327-30. PubMed ID: 24919822 [TBL] [Abstract][Full Text] [Related]
18. Depression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment. Fang H; Tu S; Sheng J; Shao A J Cell Mol Med; 2019 Apr; 23(4):2324-2332. PubMed ID: 30734486 [TBL] [Abstract][Full Text] [Related]
19. [Evidence-based therapeutic algorithms in the treatment of depression, dementia and psychosis in Parkinson's disease]. Krüger R; Weiss D MMW Fortschr Med; 2011 Apr; 153(14):29-32; quiz 33. PubMed ID: 21966866 [No Abstract] [Full Text] [Related]